English | Español
Patient Daily | Mar 17, 2026

FDA move to single pivotal study raises standards for drug applications
Patient Daily | Mar 17, 2026

Novo Holdings’ assets fell 34% in 2025 as Novo Nordisk struggled
Patient Daily | Mar 17, 2026

J&J and AbbVie CEOs receive pay increases exceeding $30 million in 2025
Patient Daily | Mar 17, 2026

BridgeBio reports positive Phase 3 results for limb-girdle muscular dystrophy drug
Patient Daily | Mar 17, 2026

Eli Lilly warns of safety risks in compounded tirzepatide formulations
Patient Daily | Mar 17, 2026

Biogen, Sarepta, and Edgewise present new data at Muscular Dystrophy Association 2026 conference
Patient Daily | Mar 17, 2026

Los Angeles aims to become a leading global life sciences hub
Patient Daily | Mar 17, 2026

Industry questions FDA’s data-sharing guidance for cell and gene therapy sector

Trending
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

Five therapies show progress in multiple myeloma treatment landscape
+ Pharmaceuticals
Patient Daily | Mar 11, 2026

Alnylam partners with Tenaya Therapeutics on genetic heart disease research
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

FDA advisory committee to review two AstraZeneca cancer drugs in April meeting
+ Pharmaceuticals
Patient Daily | Mar 11, 2026

Salk scientists find key protein linking GLP-1 drug benefits to pancreatic cell health